Aim: This study investigated whether esophageal invasion length (EIL) of a tumor from the esophagogastric junction could be a possible indicator of mediastinal lymph node metastasis and survival in patients with Siewert type II adenocarcinoma. Results: Siewert type II patients with an EIL of more than 25 mm (>25 mm EIL group) had a higher incidence of overall metastasis or recurrence in the upper and middle mediastinal zones than those with an EIL of less than or equal to 25 mm (≤25 mm EIL group) (P = .001 and P < .001). Disease-free and overall survival in the >25 mm EIL group were significantly lower than those of the ≤25 mm EIL group (P < .001). None of the Siewert type II patients with metastasis or recurrence in the upper and middle mediastinal zones survived for more than 5 years. Only an EIL of more than 25 mm was a significant preoperative predictor of overall metastasis or recurrence in the upper and middle mediastinal zones (odds ratio, 8.85; 95% CI, 2.31-33.3; P = .001).
| INTRODUCTION
The worldwide incidence of adenocarcinoma of the esophagogastric junction (EGJ) has been increasing in the past few decades. [1] [2] [3] The
Siewert classification divides this entity into three subtypes according to its anatomical localization relative to the EGJ. 4 Siewert type I and type III tumors are usually treated as esophageal and gastric tumors, respectively. Because of the higher risk of mediastinal lymph node metastasis, a transthoracic and abdominal approach is frequently used for Siewert type I tumors, whereas an abdominal or transhiatal approach is commonly proposed for Siewert type III tumors. In contrast, Siewert type II tumors are considered "true" EGJ adenocarcinomas. 5 However, the optimal surgical approach for this tumor remains unclear. Although dissection of the lower mediastinal lymph nodes can be carried out by either a transthoracic or a transhiatal approach, only a transthoracic method can be used to dissect the upper and middle mediastinal lymph nodes. As an R0 resection is essential for long-term survival after surgery for EGJ adenocarcinoma, 6 ,7 the extent of lymph node dissection should be considered as well as the extent of esophageal or gastric resection in individual
Siewert type II tumors.
Lymph node metastasis is known as a prognostic factor of esophageal cancer. Previous reports have indicated that a thorough lymph node dissection improves the survival of patients after esophagectomy. 8, 9 However, the accuracy of preoperative assessments of positive lymph node metastasis in patients with EGJ adenocarcinoma using conventional diagnostic techniques, such as computed tomography (CT) and endoscopic ultrasonography (EUS), is not yet as high as needed. 10 Moreover, given the frequent discrepancy between clinical diagnosis and pathological findings, improvements in the preoperative assessment of positive lymph node metastasis, especially mediastinal lymph node metastasis, are key to optimizing the therapeutic strategy for Siewert type II tumors. Several pathological parameters have been shown to be risk factors for lymph node metastasis in patients with Siewert type II tumors. [11] [12] [13] [14] However, because neoadjuvant chemotherapy or chemoradiotherapy has been introduced as a standard therapy for resectable EGJ adenocarcinoma, 15, 16 a new clinical indicator that predicts mediastinal lymph node metastasis prior to treatment needs to be investigated for the prompt selection of surgical strategies, including the extent of lymph node dissection.
The surgical strategy for Siewert type II tumors is mainly determined by tumor invasion of the esophageal wall and the relative risk of upper and middle mediastinal lymph node metastasis. 17, 18 Longitudinal lymphatic flow is very rich in the submucosal layer of the esophageal wall; 19, 20 however, the incidence of mediastinal lymph node metastasis is very low when the tumor is predominantly located in the abdominal cavity and has not massively invaded the thoracic cavity. 21 23 The EGJ was defined as the distal end of the lower esophageal palisade vessels or as the upper ends of the gastric mucosal folds by endoscopic examination and was defined as the narrowest locus of the lower esophagus by esophagogastrography.
The EIL was subsequently determined as the distance from the EGJ to the proximal edge of the tumor. In some advanced circumferential tumors, the EIL was determined from the findings obtained by both endoscopy and esophagogastrography: observation of the cardia from the stomach and His angle. The Siewert classification was determined according to the dominant area of tumor invasion and the epicenter of the tumor.
Areas of lymph node metastases were recorded according to the lymph node stations adopted by the Japanese classifications. 24 (Figure 1 ). There were 118 patients whose EIL was less than or equal to 25 mm (≤25 mm EIL group) and 50 patients whose EIL was more than 25 mm (>25 mm EIL group).
Patient characteristics were compared between the ≤25 mm EIL group and the >25 mm EIL group (Table 4) . Tumor stages in the >25 mm EIL group were significantly more advanced than those in the
≤25 mm EIL group (P < .001). Lymphatic and venous invasions were significantly more frequent in the >25 mm EIL group (P < .001 and P = .002, respectively). Overall metastasis or recurrence was compared between the ≤25 mm EIL group and the >25 mm EIL group (Table 5) . Rates of overall metastasis or recurrence in the cervical, upper, middle, lower mediastinal, and abdominal zones were significantly higher in the >25 mm EIL group than in the ≤25 mm EIL group (P = .007, P = .01, P < .001, P = .002, and P < .001, respectively).
| Overall survival and risk assessment of mediastinal lymph node metastasis in Siewert type II tumors
Median duration of the follow-up period for all the patients was 60 months. Estimated 5-year disease-free survival (DFS) rates for the ≤25 mm EIL group and the >25 mm EIL group were 67.1% and 41.3%, respectively (P < .001) (Figure 2A ). Estimated 5-year OS rates for the ≤25 mm EIL group and the >25 mm EIL group were 66.8%
and 40.9%, respectively (P < .001) ( Figure 2B ). The 5-year OS rates of the Siewert type II patients without overall metastasis or recurrence in the upper mediastinal, middle mediastinal, lower mediastinal, and abdominal zones were 64.7%, 62.8%, 64.5%, and 52.3%, respectively ( Figure 3 ). In contrast, the rates of those with overall metastasis or recurrence in the upper mediastinal, middle mediastinal, lower mediastinal, and abdominal zones were 0%, 0%, 37.5%, and 41.9%, respectively, and these differences between patients with and those without overall metastasis or recurrence in each of the zones were significant for Siewert type II tumors (P < .001, P < .001, P = .013, and P < .001, respectively In the present study, we showed that the EIL was significantly Besides the biases arising from the different surgical procedures and the lack of treatment allocation, the present study had several other limitations. We determined the cut-off value and carried out further analyses. However, the study was carried out retrospectively; therefore, the robustness of the cut-off value should be investigated in future analyses. Moreover, the sample size was unequally distributed into individual groups. Usefulness of EIL in patients with a large hiatal hernia also remains unknown. Therefore, to address these concerns, a large number of patients with an EIL of more than 25 mm is required to investigate the exact role of EIL in Siewert type II tumors. 
